Conversely, downregulated BCL6B expression is observed in bladder urothelial carcinoma, invasive breast cancer, chromophobe renal carcinoma, renal papillary cell carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, endometrial cancer, and cervical cancers. The gene discussed is BCL6B; the disease is cervical cancer.